Lataa...
Fractionated palliative thoracic radiotherapy in non-small cell lung cancer – futile or worth-while?
BACKGROUND: Palliative thoracic radiotherapy (PTR) can relieve symptoms originating from intra-thoracic disease. The optimal timing and fractionation of PTR is unknown. Time to effect is 2 months. The primary aim of this retrospective study was to investigate survival after PTR, hypothesizing that a...
Tallennettuna:
| Julkaisussa: | BMC Palliat Care |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5756366/ https://ncbi.nlm.nih.gov/pubmed/29304789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12904-017-0270-4 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|